Unacceptable Principal Diagnosis Codes
ICD-10-CM codes identified as unacceptable when used as principal diagnosis by MCE edit logic.
Source: Definitions of Medicare Code Edits v44.0, edit 9.
Advertisements
Codes on this list
2,666 codes, page 7 of 27.
- T38.906AUnderdosing of unspecified hormone antagonists, initial encounter
- T38.906DUnderdosing of unspecified hormone antagonists, subsequent encounter
- T38.906SUnderdosing of unspecified hormone antagonists, sequela
- T38.995AAdverse effect of other hormone antagonists, initial encounter
- T38.995DAdverse effect of other hormone antagonists, subsequent encounter
- T38.995SAdverse effect of other hormone antagonists, sequela
- T38.996AUnderdosing of other hormone antagonists, initial encounter
- T38.996DUnderdosing of other hormone antagonists, subsequent encounter
- T38.996SUnderdosing of other hormone antagonists, sequela
- T39.015AAdverse effect of aspirin, initial encounter
- T39.015DAdverse effect of aspirin, subsequent encounter
- T39.015SAdverse effect of aspirin, sequela
- T39.016AUnderdosing of aspirin, initial encounter
- T39.016DUnderdosing of aspirin, subsequent encounter
- T39.016SUnderdosing of aspirin, sequela
- T39.095AAdverse effect of salicylates, initial encounter
- T39.095DAdverse effect of salicylates, subsequent encounter
- T39.095SAdverse effect of salicylates, sequela
- T39.096AUnderdosing of salicylates, initial encounter
- T39.096DUnderdosing of salicylates, subsequent encounter
- T39.096SUnderdosing of salicylates, sequela
- T39.1X5AAdverse effect of 4-Aminophenol derivatives, initial encounter
- T39.1X5DAdverse effect of 4-Aminophenol derivatives, subsequent encounter
- T39.1X5SAdverse effect of 4-Aminophenol derivatives, sequela
- T39.1X6AUnderdosing of 4-Aminophenol derivatives, initial encounter
- T39.1X6DUnderdosing of 4-Aminophenol derivatives, subsequent encounter
- T39.1X6SUnderdosing of 4-Aminophenol derivatives, sequela
- T39.2X5AAdverse effect of pyrazolone derivatives, initial encounter
- T39.2X5DAdverse effect of pyrazolone derivatives, subsequent encounter
- T39.2X5SAdverse effect of pyrazolone derivatives, sequela
- T39.2X6AUnderdosing of pyrazolone derivatives, initial encounter
- T39.2X6DUnderdosing of pyrazolone derivatives, subsequent encounter
- T39.2X6SUnderdosing of pyrazolone derivatives, sequela
- T39.315AAdverse effect of propionic acid derivatives, initial encounter
- T39.315DAdverse effect of propionic acid derivatives, subsequent encounter
- T39.315SAdverse effect of propionic acid derivatives, sequela
- T39.316AUnderdosing of propionic acid derivatives, initial encounter
- T39.316DUnderdosing of propionic acid derivatives, subsequent encounter
- T39.316SUnderdosing of propionic acid derivatives, sequela
- T39.395AAdverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], initial encounter
- T39.395DAdverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], subsequent encounter
- T39.395SAdverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], sequela
- T39.396AUnderdosing of other nonsteroidal anti-inflammatory drugs [NSAID], initial encounter
- T39.396DUnderdosing of other nonsteroidal anti-inflammatory drugs [NSAID], subsequent encounter
- T39.396SUnderdosing of other nonsteroidal anti-inflammatory drugs [NSAID], sequela
- T39.4X5AAdverse effect of antirheumatics, not elsewhere classified, initial encounter
- T39.4X5DAdverse effect of antirheumatics, not elsewhere classified, subsequent encounter
- T39.4X5SAdverse effect of antirheumatics, not elsewhere classified, sequela
- T39.4X6AUnderdosing of antirheumatics, not elsewhere classified, initial encounter
- T39.4X6DUnderdosing of antirheumatics, not elsewhere classified, subsequent encounter
- T39.4X6SUnderdosing of antirheumatics, not elsewhere classified, sequela
- T39.8X5AAdverse effect of other nonopioid analgesics and antipyretics, not elsewhere classified, initial encounter
- T39.8X5DAdverse effect of other nonopioid analgesics and antipyretics, not elsewhere classified, subsequent encounter
- T39.8X5SAdverse effect of other nonopioid analgesics and antipyretics, not elsewhere classified, sequela
- T39.8X6AUnderdosing of other nonopioid analgesics and antipyretics, not elsewhere classified, initial encounter
- T39.8X6DUnderdosing of other nonopioid analgesics and antipyretics, not elsewhere classified, subsequent encounter
- T39.8X6SUnderdosing of other nonopioid analgesics and antipyretics, not elsewhere classified, sequela
- T39.95XAAdverse effect of unspecified nonopioid analgesic, antipyretic and antirheumatic, initial encounter
- T39.95XDAdverse effect of unspecified nonopioid analgesic, antipyretic and antirheumatic, subsequent encounter
- T39.95XSAdverse effect of unspecified nonopioid analgesic, antipyretic and antirheumatic, sequela
- T39.96XAUnderdosing of unspecified nonopioid analgesic, antipyretic and antirheumatic, initial encounter
- T39.96XDUnderdosing of unspecified nonopioid analgesic, antipyretic and antirheumatic, subsequent encounter
- T39.96XSUnderdosing of unspecified nonopioid analgesic, antipyretic and antirheumatic, sequela
- T40.0X5AAdverse effect of opium, initial encounter
- T40.0X5DAdverse effect of opium, subsequent encounter
- T40.0X5SAdverse effect of opium, sequela
- T40.0X6AUnderdosing of opium, initial encounter
- T40.0X6DUnderdosing of opium, subsequent encounter
- T40.0X6SUnderdosing of opium, sequela
- T40.2X5AAdverse effect of other opioids, initial encounter
- T40.2X5DAdverse effect of other opioids, subsequent encounter
- T40.2X5SAdverse effect of other opioids, sequela
- T40.2X6AUnderdosing of other opioids, initial encounter
- T40.2X6DUnderdosing of other opioids, subsequent encounter
- T40.2X6SUnderdosing of other opioids, sequela
- T40.3X5AAdverse effect of methadone, initial encounter
- T40.3X5DAdverse effect of methadone, subsequent encounter
- T40.3X5SAdverse effect of methadone, sequela
- T40.3X6AUnderdosing of methadone, initial encounter
- T40.3X6DUnderdosing of methadone, subsequent encounter
- T40.3X6SUnderdosing of methadone, sequela
- T40.415AAdverse effect of fentanyl or fentanyl analogs, initial encounter
- T40.415DAdverse effect of fentanyl or fentanyl analogs, subsequent encounter
- T40.415SAdverse effect of fentanyl or fentanyl analogs, sequela
- T40.416AUnderdosing of fentanyl or fentanyl analogs, initial encounter
- T40.416DUnderdosing of fentanyl or fentanyl analogs, subsequent encounter
- T40.416SUnderdosing of fentanyl or fentanyl analogs, sequela
- T40.425AAdverse effect of tramadol, initial encounter
- T40.425DAdverse effect of tramadol, subsequent encounter
- T40.425SAdverse effect of tramadol, sequela
- T40.426AUnderdosing of tramadol, initial encounter
- T40.426DUnderdosing of tramadol, subsequent encounter
- T40.426SUnderdosing of tramadol, sequela
- T40.495AAdverse effect of other synthetic narcotics, initial encounter
- T40.495DAdverse effect of other synthetic narcotics, subsequent encounter
- T40.495SAdverse effect of other synthetic narcotics, sequela
- T40.496AUnderdosing of other synthetic narcotics, initial encounter
- T40.496DUnderdosing of other synthetic narcotics, subsequent encounter
- T40.496SUnderdosing of other synthetic narcotics, sequela
- T40.5X5AAdverse effect of cocaine, initial encounter